Nitrendipin Abz (Nitrendipine)

Nitrendipine, the active ingredient in Nitrendipin Abz, is a calcium channel blocker presented as a tablet for oral use. It belongs to the dihydropyridine subclass and is indicated for the management of hypertension in adult patients, helping to lower elevated blood pressure by relaxing vascular smooth muscle.

GNH USA supplies Nitrendipin Abz as a licensed, Good Distribution Practice‑compliant international pharmaceutical supplier, providing the product to hospitals, pharmacies and clinics worldwide under appropriate regulatory frameworks. The company ensures quality assurance, batch traceability and timely delivery across multiple markets.

Nitrendipine is used to treat conditions related to elevated vascular resistance and hypertension. - Hypertension: lowers systolic and diastolic blood pressure in patients with high blood pressure. - Essential hypertension: provides long‑term blood pressure control in adults. - Isolated systolic hypertension: reduces elevated systolic pressure in older patients. - Secondary hypertension: assists in blood pressure management when caused by renal or endocrine disorders.

Nitrendipine may be associated with a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Headache: mild to moderate pain often occurring after dose initiation. - Flushing: transient warmth and redness of the skin. - Peripheral edema: swelling of the ankles or lower legs. - Dizziness: light‑headed sensation, especially when standing quickly.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure that may cause fainting. - Myocardial infarction: rare occurrence of heart attack. - Anaphylactic reaction: life‑threatening allergic response requiring immediate medical attention.

When prescribing nitrendipine, clinicians should consider several precautionary measures to ensure safe use. - Blood pressure monitoring: check baseline and periodic readings to avoid excessive hypotension. - Cardiovascular disease: use cautiously in patients with recent myocardial infarction or unstable angina. - Liver impairment: dose adjustment may be required in moderate to severe hepatic dysfunction. - Elderly patients: start with lower dose due to increased sensitivity to vasodilatory effects. - Drug interactions: review concomitant medications that affect calcium channel blockers. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Nitrendipine can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase plasma levels, risking toxicity. - Simultaneous use with other antihypertensives (e.g., ACE inhibitors, diuretics): can cause additive hypotensive effect.

Moderate Interactions (Monitor Closely): - CYP3A4 inducers (e.g., rifampicin, carbamazepine): may reduce drug concentration, diminishing effect. - Grapefruit juice: can modestly increase nitrendipine exposure. - Non‑steroidal anti‑inflammatory drugs (NSAIDs): may blunt antihypertensive response.